Responded on prior anti-EGFR treatments, yes vs. no
|
3.38
|
(1.27, 9.31)
|
0.019
|
0.70
|
(0.43, 1.15)
|
0.156
|
Interval length, ≥ median vs. < median
|
2.37
|
(0.89, 6.31)
|
0.086
|
0.72
|
(0.45, 1.16)
|
0.177
|
Race, White vs. non-White
|
0.41
|
(0.13, 1.25)
|
0.116
|
1.75
|
(1.02, 3.01)
|
0.043
|
Age, ≥ 60 years vs. < 60 years
|
0.70
|
(0.25, 1.96)
|
0.500
|
1.10
|
(0.65, 1.87)
|
0.718
|
Gender, male vs. female
|
1.28
|
(0.50, 3.25)
|
0.611
|
0.78
|
(0.49, 1.24)
|
0.295
|
RMH Score, ≥ 2 vs. < 2
|
0.79
|
(0.29, 2.11)
|
0.633
|
1.32
|
(0.81, 2.16)
|
0.273
|
PS by ECOG, ≥ 1 versus < 1
|
0.76
|
(0.28, 2.10)
|
0.597
|
1.25
|
(0.76, 2.05)
|
0.381
|